WinstonWınston
Back
Kewaunee Scientific Corporation logo

Kewaunee Scientific Corporation

KEQU
54
Furnishings, Fixtures & Appliances · Consumer Cyclical
Price
$37.07
+0.60 (+1.65%)
Market Cap
$106.3M
Exchange
NASDAQ
Winston Score
54
Winston is curious
Mixed quality — meaningful strengths and weaknesses.
Data as of Aug 23, 2026 · filings through Apr 30, 2026
How the score breaks down
Quality
Good
Growth
Mixed
Cash Flow
Strong
Stability
Strong
Valuation
Good

Share count rising — dilution

+7.1% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 2.8M (2022) → 3.0M (2026)

Winston Score History

The full picture

Kewaunee Scientific Corporation makes laboratory furniture and casework — things like cabinets, workbenches, fume hoods, and storage systems used in science labs. Its main customers are universities, hospitals, pharmaceutical companies, and government research facilities. The company has been building lab furniture since 1906, making it one of the oldest and most established names in this niche market.

Kewaunee earns revenue by selling and installing custom-designed lab furniture, primarily on a project-by-project basis rather than through recurring subscriptions. It operates mainly in the United States and India, with some international sales, and generates roughly $200 million in annual revenue. Its long history and specialized expertise in lab environments give it a degree of brand recognition among architects and lab planners, but the business faces ongoing pressure from construction project cycles, raw material costs, and competition from other contract furniture makers. Growth depends heavily on capital spending at research institutions and life sciences companies.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-7.5% YoY

YoY Growth Rate

Revenue declining

EPS Growth

-30.6% YoY

YoY Growth Rate

Earnings declining

R&D Spend

$898,000/ year

0.3% of revenue

Below sector average (4%)

Research and development spending

Insider Activity

25.7%ownership

Rising

Insiders increasing their stake — aligned with shareholders

Cash Position

Cash flow positive

$14M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Revenue declining

Kewaunee Scientific Corporation's revenue is actually shrinking. In a growth stock, that removes the core investment thesis. The low Winston Score here may be warranted — unless there's a turnaround story.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
29.8%
Modest — 29.8% gross margin
Profit after running costs
Operating Margin
7.3%
Modest — 7.3% operating margin
Return on the money invested
ROCE
17.7%
Strong — 17.7% return on capital

ROIC between 15% and 25%. Every dollar invested in the business earns 15 to 25 cents back per year.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+17.3%
Fast-growing sales (+17.3% YoY)
Profit growth
EPS YoY
-16.0%
Earnings shrinking (-16.0% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

How steady the profit is
EPS Consistency
2/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
194%
Turns 194% of profit into real cash
Spare cash per sale
FCF Margin
5.2%
Thin free cash flow (5.2%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.26
Conservative — low debt load (0.26)
Covers its interest
Interest Cover
4.33x
Adequate interest coverage (4.3x)

Interest coverage between 3 and 8. Profits cover interest several times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
11.1x
Attractive valuation — P/E 11.1

P/E in the normal range. Price is roughly $15 for every $1 of yearly profit.

Cheaper or dearer next year
P/E vs Forward
-6.5
SLOWING
Earnings expected to fall — forward P/E higher than today

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial